HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity
- Autores
- Prince, Thomas L.; Lang, Benjamin J.; Guerrero Gimenez, Martin Eduardo; Fernandez Muñoz, Juan Manuel; Ackerman, Andrew; Calderwood, Stuart K.
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Heat shock factor 1 (HSF1) is the primary component for initiation of the powerful heat shock response (HSR) in eukaryotes. The HSR is an evolutionarily conserved mechanism for responding to proteotoxic stress and involves the rapid expression of heat shock protein (HSP) molecular chaperones that promote cell viability by facilitating proteostasis. HSF1 activity is amplified in many tumor contexts in a manner that resembles a chronic state of stress, characterized by high levels of HSP gene expression as well as HSF1-mediated non-HSP gene regulation. HSF1 and its gene targets are essential for tumorigenesis across several experimental tumor models, and facilitate metastatic and resistant properties within cancer cells. Recent studies have suggested the significant potential of HSF1 as a therapeutic target and have motivated research efforts to understand the mechanisms of HSF1 regulation and develop methods for pharmacological intervention. We review what is currently known regarding the contribution of HSF1 activity to cancer pathology, its regulation and expression across human cancers, and strategies to target HSF1 for cancer therapy.
Fil: Prince, Thomas L.. Geisinger Clinic. Department of Molecular Functional Genomics; Estados Unidos
Fil: Lang, Benjamin J.. Harvard Medical School; Estados Unidos
Fil: Guerrero Gimenez, Martin Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
Fil: Fernandez Muñoz, Juan Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
Fil: Ackerman, Andrew. Geisinger Clinic. Department of Molecular Functional Genomics; Estados Unidos
Fil: Calderwood, Stuart K.. Harvard Medical School; Estados Unidos - Materia
-
CANCER
CANCER THERAPY
HEAT SHOCK FACTOR 1
HEAT SHOCK PROTEINS
HEAT SHOCK RESPONSE
HSF1
HSF1 EXPRESSION IN CANCER
HSF1 IN CANCER
HSPS
HSR
METASTASIS
MOLECULAR CHAPERONES
TUMORIGENESIS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/126784
Ver los metadatos del registro completo
id |
CONICETDig_1789498b11bd721d6f2c5a0e9ed59c59 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/126784 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer MorbidityPrince, Thomas L.Lang, Benjamin J.Guerrero Gimenez, Martin EduardoFernandez Muñoz, Juan ManuelAckerman, AndrewCalderwood, Stuart K.CANCERCANCER THERAPYHEAT SHOCK FACTOR 1HEAT SHOCK PROTEINSHEAT SHOCK RESPONSEHSF1HSF1 EXPRESSION IN CANCERHSF1 IN CANCERHSPSHSRMETASTASISMOLECULAR CHAPERONESTUMORIGENESIShttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Heat shock factor 1 (HSF1) is the primary component for initiation of the powerful heat shock response (HSR) in eukaryotes. The HSR is an evolutionarily conserved mechanism for responding to proteotoxic stress and involves the rapid expression of heat shock protein (HSP) molecular chaperones that promote cell viability by facilitating proteostasis. HSF1 activity is amplified in many tumor contexts in a manner that resembles a chronic state of stress, characterized by high levels of HSP gene expression as well as HSF1-mediated non-HSP gene regulation. HSF1 and its gene targets are essential for tumorigenesis across several experimental tumor models, and facilitate metastatic and resistant properties within cancer cells. Recent studies have suggested the significant potential of HSF1 as a therapeutic target and have motivated research efforts to understand the mechanisms of HSF1 regulation and develop methods for pharmacological intervention. We review what is currently known regarding the contribution of HSF1 activity to cancer pathology, its regulation and expression across human cancers, and strategies to target HSF1 for cancer therapy.Fil: Prince, Thomas L.. Geisinger Clinic. Department of Molecular Functional Genomics; Estados UnidosFil: Lang, Benjamin J.. Harvard Medical School; Estados UnidosFil: Guerrero Gimenez, Martin Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Fernandez Muñoz, Juan Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Ackerman, Andrew. Geisinger Clinic. Department of Molecular Functional Genomics; Estados UnidosFil: Calderwood, Stuart K.. Harvard Medical School; Estados UnidosMDPI2020-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/126784Prince, Thomas L.; Lang, Benjamin J.; Guerrero Gimenez, Martin Eduardo; Fernandez Muñoz, Juan Manuel; Ackerman, Andrew; et al.; HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity; MDPI; Cells; 9; 4; 4-2020; 1-272073-4409CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2073-4409/9/4/1046info:eu-repo/semantics/altIdentifier/doi/10.3390/cells9041046info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:41:01Zoai:ri.conicet.gov.ar:11336/126784instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:41:01.601CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity |
title |
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity |
spellingShingle |
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity Prince, Thomas L. CANCER CANCER THERAPY HEAT SHOCK FACTOR 1 HEAT SHOCK PROTEINS HEAT SHOCK RESPONSE HSF1 HSF1 EXPRESSION IN CANCER HSF1 IN CANCER HSPS HSR METASTASIS MOLECULAR CHAPERONES TUMORIGENESIS |
title_short |
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity |
title_full |
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity |
title_fullStr |
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity |
title_full_unstemmed |
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity |
title_sort |
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity |
dc.creator.none.fl_str_mv |
Prince, Thomas L. Lang, Benjamin J. Guerrero Gimenez, Martin Eduardo Fernandez Muñoz, Juan Manuel Ackerman, Andrew Calderwood, Stuart K. |
author |
Prince, Thomas L. |
author_facet |
Prince, Thomas L. Lang, Benjamin J. Guerrero Gimenez, Martin Eduardo Fernandez Muñoz, Juan Manuel Ackerman, Andrew Calderwood, Stuart K. |
author_role |
author |
author2 |
Lang, Benjamin J. Guerrero Gimenez, Martin Eduardo Fernandez Muñoz, Juan Manuel Ackerman, Andrew Calderwood, Stuart K. |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
CANCER CANCER THERAPY HEAT SHOCK FACTOR 1 HEAT SHOCK PROTEINS HEAT SHOCK RESPONSE HSF1 HSF1 EXPRESSION IN CANCER HSF1 IN CANCER HSPS HSR METASTASIS MOLECULAR CHAPERONES TUMORIGENESIS |
topic |
CANCER CANCER THERAPY HEAT SHOCK FACTOR 1 HEAT SHOCK PROTEINS HEAT SHOCK RESPONSE HSF1 HSF1 EXPRESSION IN CANCER HSF1 IN CANCER HSPS HSR METASTASIS MOLECULAR CHAPERONES TUMORIGENESIS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Heat shock factor 1 (HSF1) is the primary component for initiation of the powerful heat shock response (HSR) in eukaryotes. The HSR is an evolutionarily conserved mechanism for responding to proteotoxic stress and involves the rapid expression of heat shock protein (HSP) molecular chaperones that promote cell viability by facilitating proteostasis. HSF1 activity is amplified in many tumor contexts in a manner that resembles a chronic state of stress, characterized by high levels of HSP gene expression as well as HSF1-mediated non-HSP gene regulation. HSF1 and its gene targets are essential for tumorigenesis across several experimental tumor models, and facilitate metastatic and resistant properties within cancer cells. Recent studies have suggested the significant potential of HSF1 as a therapeutic target and have motivated research efforts to understand the mechanisms of HSF1 regulation and develop methods for pharmacological intervention. We review what is currently known regarding the contribution of HSF1 activity to cancer pathology, its regulation and expression across human cancers, and strategies to target HSF1 for cancer therapy. Fil: Prince, Thomas L.. Geisinger Clinic. Department of Molecular Functional Genomics; Estados Unidos Fil: Lang, Benjamin J.. Harvard Medical School; Estados Unidos Fil: Guerrero Gimenez, Martin Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina Fil: Fernandez Muñoz, Juan Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina Fil: Ackerman, Andrew. Geisinger Clinic. Department of Molecular Functional Genomics; Estados Unidos Fil: Calderwood, Stuart K.. Harvard Medical School; Estados Unidos |
description |
Heat shock factor 1 (HSF1) is the primary component for initiation of the powerful heat shock response (HSR) in eukaryotes. The HSR is an evolutionarily conserved mechanism for responding to proteotoxic stress and involves the rapid expression of heat shock protein (HSP) molecular chaperones that promote cell viability by facilitating proteostasis. HSF1 activity is amplified in many tumor contexts in a manner that resembles a chronic state of stress, characterized by high levels of HSP gene expression as well as HSF1-mediated non-HSP gene regulation. HSF1 and its gene targets are essential for tumorigenesis across several experimental tumor models, and facilitate metastatic and resistant properties within cancer cells. Recent studies have suggested the significant potential of HSF1 as a therapeutic target and have motivated research efforts to understand the mechanisms of HSF1 regulation and develop methods for pharmacological intervention. We review what is currently known regarding the contribution of HSF1 activity to cancer pathology, its regulation and expression across human cancers, and strategies to target HSF1 for cancer therapy. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-04 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/126784 Prince, Thomas L.; Lang, Benjamin J.; Guerrero Gimenez, Martin Eduardo; Fernandez Muñoz, Juan Manuel; Ackerman, Andrew; et al.; HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity; MDPI; Cells; 9; 4; 4-2020; 1-27 2073-4409 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/126784 |
identifier_str_mv |
Prince, Thomas L.; Lang, Benjamin J.; Guerrero Gimenez, Martin Eduardo; Fernandez Muñoz, Juan Manuel; Ackerman, Andrew; et al.; HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity; MDPI; Cells; 9; 4; 4-2020; 1-27 2073-4409 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2073-4409/9/4/1046 info:eu-repo/semantics/altIdentifier/doi/10.3390/cells9041046 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614439975780352 |
score |
13.070432 |